Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis
about
Characterization of microRNA expression profiles in Leishmania-infected human phagocytes.Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation.STAT6-Dependent Collagen Synthesis in Human Fibroblasts Is Induced by Bovine Milk.M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis.Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.Mycobacterium leprae-induced Insulin-like Growth Factor I attenuates antimicrobial mechanisms, promoting bacterial survival in macrophages.Therapeutic effect of ursolic acid in experimental visceral leishmaniasisThe function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis.Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in MacrophagesIn vivo characterization of two additional Leishmania donovani strains using the murine and hamster model.Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.M1 polarization and the effect of PGE2 on TNF-α production by lymph node cells from dogs with visceral leishmaniasis.Leishmania proteophosphoglycans regurgitated from infected sand flies accelerate dermal wound repair and exacerbate leishmaniasis via insulin-like growth factor 1-dependent signalling.Insulin-Like Growth Factor-I as an Effector Element of the Cytokine IL-4 in the Development of a Infection
P2860
Q34870671-276A14C7-FD1E-4A03-9852-49DFF998AAAAQ34968517-AADAE7C4-3F99-4F26-AE08-F0293DA24BE4Q35680805-D9635BBD-EFCB-4905-BC7B-BF43860E4699Q35819318-EB2889A9-EE65-42A0-A4F6-39C0509C2351Q36253846-23703EAC-E90B-43B6-B3CB-BC10EA54EE38Q36265092-5C9158A3-6BF5-4609-9AAB-9A6EA6B410D9Q36990750-2044418A-0EAD-4C3D-A595-F6B304C04573Q37503612-C2636171-EA37-404A-94A7-3656631629C2Q37706203-D524F637-B3AE-4B46-BF96-D35F74F4DDECQ38266887-E6DA1D9A-F3FB-46D3-B970-A4E3E57BA71AQ39124054-41FCC68D-AB15-401F-86BB-CE7568054174Q39543850-916634C3-4C7F-4E2B-A76A-5867DEE3013DQ40480786-75076BE0-C4F8-4631-84E1-E3E2CDE4AC42Q47551102-1345EFFA-4014-4CA2-AC91-8A4273E47F86Q58861573-FB0D79A9-7E58-4574-86AD-415DE5123DB7
P2860
Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@ast
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@en
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@nl
type
label
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@ast
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@en
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@nl
prefLabel
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@ast
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@en
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@nl
P2093
P2860
P3181
P1433
P1476
Growth factor and Th2 cytokine ...... imental visceral leishmaniasis
@en
P2093
Alda M da Cruz
Audrie A Medina
Bruno L Travi
E Yaneth Osorio
Omar A Saldarriaga
Peter C Melby
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1004165
P407
P577
2014-06-01T00:00:00Z